Hu Kangyi, Song Min, Song Ting, Jia Xiao, Song Yongjia
Clinical College of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, People's Republic of China.
J Inflamm Res. 2025 Mar 19;18:4121-4142. doi: 10.2147/JIR.S514002. eCollection 2025.
Osteoarthritis (OA) is a degenerative joint disease influenced by multiple factors, with its etiology arising from intricate interactions among mechanical stress, inflammatory processes, and disruptions in bone metabolism. Recent research in bone immunology indicates that immune-mediated mechanisms significantly contribute to the progression of OA, highlighting the interactions among immune cells, cytokine networks, and bone components. Immune cells interact with osteoclasts, osteoblasts, and chondrocytes in a variety of ways. These interactions foster a pro-inflammatory microenvironment, contributing to cartilage breakdown, synovial inflammation, and the sclerosis of subchondral bone. In this article, we present a comprehensive review of bone immunology in OA, focusing on the critical role of immune cells and their cytokine-mediated feedback loops in the pathophysiology of OA. In addition, we are exploring novel therapeutic strategies targeting bone immune pathways, including macrophage polarization, T-cell differentiation, and stem cell therapy to restore the metabolic balance between immunity and bone. By integrating cutting-edge research in bone immunology, this review integrates the latest advancements in bone immunology to construct a comprehensive framework for unraveling the pathogenesis of OA, laying a theoretical foundation for the development of innovative precision therapies.
骨关节炎(OA)是一种受多种因素影响的退行性关节疾病,其病因源于机械应力、炎症过程和骨代谢紊乱之间的复杂相互作用。骨免疫学的最新研究表明,免疫介导机制在OA进展中起重要作用,凸显了免疫细胞、细胞因子网络和骨成分之间的相互作用。免疫细胞以多种方式与破骨细胞、成骨细胞和软骨细胞相互作用。这些相互作用促进了促炎微环境的形成,导致软骨破坏、滑膜炎症和软骨下骨硬化。在本文中,我们全面综述了OA中的骨免疫学,重点关注免疫细胞及其细胞因子介导的反馈回路在OA病理生理学中的关键作用。此外,我们正在探索针对骨免疫途径的新型治疗策略,包括巨噬细胞极化、T细胞分化和干细胞疗法,以恢复免疫与骨之间的代谢平衡。通过整合骨免疫学的前沿研究,本综述整合了骨免疫学的最新进展,构建了一个全面的框架来阐明OA的发病机制,为创新精准疗法的开发奠定理论基础。
Int J Mol Sci. 2024-10-9
Prog Biophys Mol Biol. 2017-12-22
Front Cell Dev Biol. 2021-8-3
Life (Basel). 2025-8-4
Int Immunopharmacol. 2024-5-10
Bone Res. 2024-4-1
Int J Mol Sci. 2024-2-9